Medical team

Head of the Hematology Department

Dr. Jordi Fontcuberta Boj, Head of the Hematology Department at the Dexeus University Hospital, holds a degree in Medicine and Surgery from the Autonomous University of Barcelona, and is ​​certified as a Specialist in Hematology and Hemotherapy. He is a Doctor of Medicine and Surgery, with cum laude honors.

Dr. Fontcuberta is an expert in Thrombosis and Hemostasis at national and international levels and he is specialized in inherited and acquired thrombophilia, the diagnosis and treatment of hemorrhagic diseases, the study of hypercoagulability states, and the use of antithrombotic, anticoagulant and fibrinolytic drugs.

He is currently the Head of the Hemostasis and Thrombosis Unit at the Sant Pau Hospital in Barcelona, member of the Executive Committee and a Spanish Associate of the European Prospective Cohort on Thrombophilia (EPCOT). He is also the leader of the Genetic Analysis of Idiopathic Thrombophilia (GAIT) project, one of the major international projects in the search for new genes related to thrombosis.

He is an Associate Professor at the Autonomous University of Barcelona, and has been a member of the Department of Medicine since 2010.

Ministry of Education, Council of Universities, National Accreditation for University Professors (ANECA). July 2010.

Dr. Fontcuberta has been co-author of more than 250 scientific and of 400 communications to national and international meetings. He has participated in 120 symposiums and round tables, given 100 talks, and organized around 20 courses in the field of ​​Hemostasis and Thrombosis.He has also authored 6 books and 40 book chapters.

Jordi Fontcuberta is the recipient of 20 national and international research grants (NIH, EC), the holder of 3 patents, 8 national and international awards, and the director of 8 doctoral theses.

He is member of the Spanish Society for Hematology and Hemotherapy, the Spanish Society for Thrombosis and Hemostasis, the International Society of Thrombosis and Hemostasis, the American Association for the Advancement of Science, amongst others.